Background: Infections are common following stroke and associated with worse outcome. Using an animal model of pneumonia, we assessed the effect of infection and its treatment on the immune response and stroke outcome. Methods: Lewis rats were subjected to transient cerebral ischemia and survived for 4 weeks. One day after stroke animals were exposed to aerosolized Staphylococcus aureus, Pseudomonas aeruginosa or saline. Antibiotics (ceftiofur or enrofloxacin) were started immediately after exposure or delayed for 3 days. Behavioral tests were performed weekly. ELISPOT assays were done on lymphocytes from spleen and brain to assess autoimmune responses to myelin basic protein (MBP). Results: Among animals that received immediate antibiotic therapy, infection was associated with worse outcome in ceftiofur but not enrofloxacin treated animals. (The outcome with immediate enrofloxacin therapy was so impaired that further worsening may have been difficult to detect.) A delay in antibiotic therapy was associated with better outcomes in both ceftiofur and enrofloxacin treated animals. Infection was associated with an increased likelihood of developing TH1(+) responses to MBP in non-infarcted brain (OR = 2.94 [1.07, 8.12]; P = 0.04), and TH1(+) responses to MBP in spleen and non-infarcted brain were independently associated with a decreased likelihood of stroke recovery (OR = 0.16 [0.05, 0.51; P = 0.002 and OR = 0.32 [0.12, 0.84]; P = 0.02, respectively). Conclusions: Infection worsens stroke outcome in ceftiofur treated animals and increases TH1 responses to MBP. These data may help explain how infection worsens stroke outcome and suggest that treatment of infection may contribute to this outcome.
Introduction
Patients who become infected in the immediate post-stroke period have increased morbidity and mortality in comparison to patients who remain infection free (Westendorp et al., 2011) . We previously showed that exposure to lipopolysaccharide (LPS) during experimental stroke increases TH1 immune responses to myelin basic protein (MBP) and worsens outcome (Becker et al., 2005) . In an observational study, individuals with post-stroke pneumonia were at similar risk for developing TH1 responses to MBP and worse clinical outcome (Becker et al., 2011) . Whether early antibiotic therapy might prevent TH1 responses and improve outcome is unknown, and trials of prophylactic antibiotics to prevent post-stroke infection have had mixed results (Chamorro et al., 2005; Harms et al., 2008; Kalra et al., 2015; Schwarz et al., 2008; Westendorp et al., 2015) . In uninfected animals, treatment with enrofloxacin (a fluoroquinolone antibiotic), but not ceftiofur (a β-lactam antibiotic), leads to worse outcome after stroke (Zierath et al., 2015a) . In this study we examined the effects of pneumonia on the immune response to MBP and stroke outcome. Staphylococcus aureus and Pseudomonas aeruginosa are common respiratory pathogens after stroke and chosen here as prototypes of Gram-positive and Gram-negative infections (Hassan et al., 2006; Hilker et al., 2003; Tanzi et al., 2011; Walter et al., 2007; Yan et al., 2015) . Broad spectrum antibiotics used for empiric treatment of infection include β-lactams and fluoroquinolones; we chose ceftiofur and enrofloxacin as representatives of each class. The effects of pathogen, antibiotic and antibiotic timing on the immune response and stroke outcome were explored.
Materials and methods

Animals
Male Lewis rats (275-325 g) were purchased from Taconic Farms. All experiments were approved by the University of Washington Institutional Animal Care and Use Committee. Journal of Neuroimmunology 295-296 (2016) 68-74 
